- Carboxypeptidase U (CPU, TAFIa, CPB2) in thromboembolic disease(2021)
Auteurs: Karen Claesen, Joachim Mertens, Dorien Leenaerts, Dirk Hendriks
- Selective inhibition of carboxypeptidase U may reduce microvascular thrombosis in rat experimental stroke(2020)
Auteurs: Joachim Mertens, William Boisseau, Dorien Leenaerts, Lucas Di Meglio, Stéphane Loyau, Célina Ducroux, Martine Jandrot‐Perrus, Jean‐Baptiste Michel, Mikael Mazighi, Jean‐Philippe Desilles
Pagina's: 3325 - 3335
- Inhibition of the procarboxypeptidase U (proCPU, TAFI, proCPB2) system due to hemolysis(2019)
Auteurs: Joachim Mertens, Karen Claesen, Dorien Leenaerts, Yani Sim
Pagina's: 878 - 884
- Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood-brain barrier dysfunction(2018)
Auteurs: Joachim Mertens, Dorien Leenaerts, Raf Brouns, Sebastiaan Engelborghs, Margareta Ieven
Pagina's: 342 - 348
- Carboxypeptidase U (CPU, carboxypeptidase B2, activated thrombin-activatable fibrinolysis inhibitor) inhibition stimulates the fibrinolytic rate in different invitro models(2018)
Auteurs: Dorien Leenaerts, S. Loyau, Joachim Mertens, W. Boisseau, J. B. Michel, M. Jandrot-Perrus
Pagina's: 2057 - 2069
- Plasma carboxypeptidase U (CPU, CPB2, TAFIa) generation during in vitro clot lysis and its interplay between coagulation and fibrinolysis(2017)
Auteurs: Dorien Leenaerts, Jef Aernouts, Pieter Van Der Veken, Yani Sim
Pagina's: 1498 - 1508
- Towards improved understanding of the role of carboxypeptidase U in arterial thrombosis(2017)
Auteurs: Dorien Leenaerts
Aantal pagina's: 265
- Plasma levels of carboxypeptidase U (CPU, CPB2 or TAFIa) are elevated in patients with acute myocardial infarction(2015)
Auteurs: Dorien Leenaerts, Johan Bosmans, Pieter Van Der Veken, Yani Sim, Anne-Marie Lambeir, Dirk Hendriks
Pagina's: 2227 - 2232